New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation
The 90-day results of the STORM-PE randomised controlled trial (RCT) have demonstrated that patients with acute intermediate-high risk pulmonary embolism (PE) who were treated...
Mermaid Medical receives CE mark for Angel pulmonary embolism catheter
Mermaid Medical has today announced that the Angel catheter has officially received CE marking, enabling its commercial availability across Europe.
The Angel catheter is...
InterVene completes first 30 cases using Recana thrombectomy catheter system
InterVene has announced the successful completion of 30 cases using the Recana thrombectomy catheter system. The cases were performed across the company’s limited US...
E2 raises US$80 million series C financing for Hēlo thrombectomy platform
Endovascular Engineering (E2) today announced an oversubscribed US$80 million series C financing co-led by Gilde Healthcare and Norwest, with participation from existing investors including...
